Your browser doesn't support javascript.
loading
Mitigating the Denosumab-Induced Rebound Phenomenon with Alternating Short- and Long-Acting Anti-resorptive Therapy in a Young Boy with Severe OI Type VI.
Seale, Emily; Molina, Maria Ochoa; Carsen, Sasha; Sheffield, Holden; Koujok, Khaldoun; Robinson, Marie-Eve; Feber, Janusz; Smit, Kevin; Page, Marika; Walker, Scott; Khan, Nasrin; Konji, Victor N; Rauch, Frank; Ward, Leanne M.
Afiliação
  • Seale E; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Molina MO; The Ottawa Pediatric Bone Health Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
  • Carsen S; The Ottawa Pediatric Bone Health Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
  • Sheffield H; Endocrinology Unit, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Koujok K; The Ottawa Pediatric Bone Health Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
  • Robinson ME; Department of Surgery, University of Ottawa and Division of Pediatric Orthopedic Surgery, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
  • Feber J; Department of Paediatrics, Qikiqtani General Hospital, Iqaluit, NU, Canada.
  • Smit K; The Ottawa Pediatric Bone Health Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
  • Page M; Department of Medical Imaging, University of Ottawa and Division of Pediatric Radiology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
  • Walker S; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Khan N; The Ottawa Pediatric Bone Health Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
  • Konji VN; Department of Pediatrics, University of Ottawa and Division of Endocrinology, Children's Hospital of Eastern Ontario, The CHEO Genetic and Metabolic Bone Disorders Program, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
  • Rauch F; The Ottawa Pediatric Bone Health Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
  • Ward LM; Department of Pediatrics, University of Ottawa, Division of Pediatric Nephrology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
Calcif Tissue Int ; 112(5): 613-620, 2023 05.
Article em En | MEDLINE | ID: mdl-36867194
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteogênese Imperfeita / Conservadores da Densidade Óssea / Hipercalcemia Limite: Child / Humans / Male Idioma: En Revista: Calcif Tissue Int Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteogênese Imperfeita / Conservadores da Densidade Óssea / Hipercalcemia Limite: Child / Humans / Male Idioma: En Revista: Calcif Tissue Int Ano de publicação: 2023 Tipo de documento: Article